PTC Therapeutics, Inc. (PTCT)
63.33
+0.77
(+1.23%)
USD |
NASDAQ |
Oct 09, 10:24
PTC Therapeutics Market Cap : 5.277B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 5.213B |
| October 07, 2026 | 5.269B |
| October 06, 2026 | 5.308B |
| October 05, 2026 | 5.304B |
| October 02, 2026 | 5.288B |
| October 01, 2026 | 5.344B |
| September 30, 2026 | 5.398B |
| September 29, 2026 | 5.413B |
| September 28, 2026 | 5.495B |
| September 25, 2026 | 5.222B |
| September 24, 2026 | 5.190B |
| September 23, 2026 | 5.195B |
| September 22, 2026 | 5.496B |
| September 21, 2026 | 5.438B |
| September 18, 2026 | 5.447B |
| September 17, 2026 | 5.666B |
| September 16, 2026 | 5.632B |
| September 15, 2026 | 5.470B |
| September 14, 2026 | 5.540B |
| September 11, 2026 | 5.505B |
| September 10, 2026 | 5.614B |
| September 09, 2026 | 5.630B |
| September 08, 2026 | 5.734B |
| September 04, 2026 | 5.775B |
| September 03, 2026 | 5.950B |
| Date | Value |
|---|---|
| September 02, 2026 | 5.982B |
| September 01, 2026 | 5.880B |
| August 31, 2026 | 5.795B |
| August 28, 2026 | 5.840B |
| August 27, 2026 | 5.984B |
| August 26, 2026 | 6.057B |
| August 25, 2026 | 6.122B |
| August 24, 2026 | 5.921B |
| August 21, 2026 | 5.818B |
| August 20, 2026 | 5.876B |
| August 19, 2026 | 6.139B |
| August 18, 2026 | 6.052B |
| August 17, 2026 | 6.073B |
| August 14, 2026 | 5.975B |
| August 13, 2026 | 5.997B |
| August 12, 2026 | 6.053B |
| August 11, 2026 | 6.141B |
| August 10, 2026 | 6.219B |
| August 07, 2026 | 6.109B |
| August 06, 2026 | 5.904B |
| August 05, 2026 | 5.767B |
| August 04, 2026 | 5.758B |
| August 03, 2026 | 5.676B |
| July 31, 2026 | 5.667B |
| July 30, 2026 | 6.293B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 33.08B |
| BioMarin Pharmaceutical, Inc. | 10.66B |
| Arcturus Therapeutics Holdings, Inc. | 395.93M |
| ACADIA Pharmaceuticals, Inc. | 3.425B |
| Alnylam Pharmaceuticals, Inc. | 30.96B |
Market Cap Related Metrics
| PS Ratio | 5.373 |
| Price | 63.33 |
| Earnings Yield | -0.94% |
| Operating PE Ratio | 46.43 |